References
- Haferlach C, Bacher U, Schnittger S, et al. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosomes Cancer. 2012;51(4):328–337.
- Yagasaki F, Jinnai I, Yoshida S, et al. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5; 12)(q31; p13). Genes Chromosom Cancer. 1999;26(3):192–202.
- Cools J, Mentens N, Odero MD, et al. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4; 12)(q11-q12; p13) or t(5;12)(q31; p13). Blood. 2002;99(5):1776–1784.
- Murati A, Adelaide J, Gelsi-Boyer V, et al. t(5;12)(q23-31; p13) with ETV6-ACSL6 gene fusion in polycythemia vera. Leukemia. 2006;20(6):1175–1178.
- Katsura Y, Suzukawa K, Nanmoku T, et al. Myelodysplastic syndrome accompanied by basophilia and eosinophilia with t(5;12)(q31;p13). Cancer Genet Cytogenet. 2007;178(1):85–88.
- Gosenca D, Erben P, Haferlach C, et al. Clinical and molecular heterogeneity of eosinophilia-associated myeloproliferative neoplasms with a translocation t(5;12). Blood. 2009;114(22):4983–4983.
- Erben P, Gosenca D, Müller MC, et al. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica. 2010;95(5):738–744.
- Luca-Johnson D, Ninfea JIR, Pearson L, et al. Myeloid neoplasms with t(5; 12) and ETV6-ACSL6 gene fusion, potential mimickers of myeloid neoplasm with PDGFRB rearrangement: case report with imatinib therapy and review of the literature. Case Rep Med. 2016;2016:8324791.
- Su RJ, Jonas BA, Welborn J, et al. Chronic eosinophilic leukemia, NOS with t(5; 12)(q31; p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol. 2016;5:6–9.
- Yang Y, Lin H, Du Z, et al. Imatinib therapy in acute myeloid leukemia with DEK-NUP214 and FIP1L1-PDGFRA rearrangement: a case report. Oncol Lett. 2020;19(5):3587–3592.
- Baldazzi C, Luatti S, Marzocchi G, et al. t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities. Cancer Genet. 2022;262–263:35–39.
- Wu X, Cai H, Qiu Y, et al. ETV6-ACSL6 fusion gene in myeloid neoplasms: clinical spectrum, current practice, and outcomes. Orphanet J Rare Dis. 2020;15(1):192.
- Tang Z, Toruner GA, Tang G, et al. Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol. 2020;33(10):2035–2045.
- Di Paola J, Porter CC. ETV6-related thrombocytopenia and leukemia predisposition. Blood. 2019;134(8):663–667.
- Butt NM, Lambert J, Ali S, et al. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176(4):553–572.